TY  - JOUR
AU  - Ahmed, Saima
AU  - Maheu, Christine
AU  - Gotlieb, Walter
AU  - Batist, Gerald
AU  - Loiselle, Carmen G
PY  - 2025
DA  - 2025/3/26
TI  - Feasibility, Acceptability, and Potential Effects of a Digital Oral Anticancer Agent Intervention: Protocol for a Pilot Randomized Controlled Trial
JO  - JMIR Res Protoc
SP  - e55475
VL  - 14
KW  - oral anticancer agent
KW  - supportive intervention
KW  - medication adherence
KW  - cancer
KW  - oncology
KW  - feasibility
KW  - acceptability
KW  - digital health
KW  - anticancer
KW  - adherence
KW  - compliance
KW  - RCT
KW  - randomized controlled trial
KW  - drug
KW  - pharmacy
KW  - pharmacology
KW  - pharmacotherapy
KW  - pharmaceutic
KW  - pharmaceutical
KW  - medication
KW  - mobile phone
AB  - Background: Individuals taking oral anticancer agents (OAAs) often face important challenges, requiring more timely informational support, ongoing monitoring, and side effect management. Objective: This study, guided by the Self-Efficacy Theory, aims to assess the feasibility, acceptability, and potential effects of a comprehensive, digital OAA intervention. Methods: A 2-arm, mixed methods, pilot randomized controlled trial took place at a large university-affiliated cancer center in Montreal, Quebec, Canada. Participants (N=52) completed baseline self-report e-questionnaires and subsequently were randomly assigned to the experimental group (intervention plus usual care, n=26) or control group (usual care only, n=26). The study intervention, designed to increase medication adherence via medication adherence self-efficacy and decreased symptom distress, included (1) OAA informational videos, (2) OAA-related e-handouts and other supportive resources, (3) nurse-led follow-up calls, and (4) e-reminders to take OAAs. The e-questionnaires were completed once a week for the first month and every 2 weeks for the subsequent 4 months, or until OAA treatment was completed. A subset from both groups (n=20) participated in semistructured interviews once they completed the study requirements. Study feasibility is assessed using recruitment, retention, and response rates, as well as intervention uptake. Through e-questionnaires and exit interviews, intervention acceptability is to be assessed prospectively at baseline and retrospectively upon study completion. Potential effects are then assessed via medication adherence self-efficacy, medication adherence self-report, and symptom distress. Results: Data collection was completed by December 2023 with a final sample size of 41. Results are expected to be published in 2025. Conclusions: This study relies on a theoretically based, OAA digital intervention with modalities tailored to the needs and preferences of participants. The use of quantitative and qualitative methods enriches our understanding of the potential contributions of the intervention. In addition, following participants over the course of treatment captures potential changes in oral treatment–related processes and outcomes. Trial Registration: ClinicalTrials.gov NCT04984850; https://www.clinicaltrials.gov/study/nct04984850 International Registered Report Identifier (IRRID): DERR1-10.2196/55475 
SN  - 1929-0748
UR  - https://www.researchprotocols.org/2025/1/e55475
UR  - https://doi.org/10.2196/55475
DO  - 10.2196/55475
ID  - info:doi/10.2196/55475
ER  -